Who is a candidate for high-dose interleukin-2 therapy for melanoma?

High-dose interleukin-2 (IL-2) therapy is Food and Drug Administration (FDA)-approved and considered standard treatment for patients with metastatic melanoma.

Skin cancer patients suitable for high-dose IL-2 therapy:

  • Must be diagnosed with metastatic melanoma (melanoma that has spread to other parts of the body)
  • Must be out of bed more than 50 percent of the day
  • Have relatively normal function of heart, lungs, kidneys, and liver
  • Have brain metastases treated and stable
  • Should not take/use steroids or steroid-containing compounds

Continue Learning about Melanoma Treatment

How can early detection of melanoma affect my chance of survival?
Aurora Health CareAurora Health Care
Early detection of melanoma is critical to your chances of surviving. If caught early, melanoma is a...
More Answers
How is a melanoma removed?
Omar A. Ibrahimi, MDOmar A. Ibrahimi, MD
The gold standard treatment for melanoma remains surgical removal. Depending on how deep the melanom...
More Answers
Are there alternative treatments for melanoma?
Sigma NursingSigma Nursing
Although alternative treatments do not cure melanoma, there are several alternative options that may...
More Answers
How is melanoma treated?
Dr. Vincent T DeVita JrDr. Vincent T DeVita Jr
Once melanoma has been found and staged, your cancer care team will discuss treatment options with y...
More Answers

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.